Eton Pharmaceuticals Inc

NASDAQ:ETON   3:59:53 PM EDT
4.00
-0.22 (-5.21%)
Earnings Announcements

Eton Pharmaceuticals Reports Q3 Loss Per Share Of $0.24

Published: 11/15/2021 21:49 GMT
Eton Pharmaceuticals Inc (ETON) - Eton Pharmaceuticals Reports Third Quarter Financial Results.
Q3 Loss per Share $0.24.
Q3 Revenue $800,000.
Revenue is expected to be $12.52 Million
Adjusted EPS is expected to be $0.19

Next Quarter Revenue Guidance is expected to be $14.7 Million
Next Quarter EPS Guidance is expected to be $0.16

More details on our Analysts Page.